Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for prevention of preterm labor
ACTRN12610001017011Phase 4Recruiting
- Sponsor
- waleed elkhayat
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sildenafil in Preterm labor (PTL) and preterm birth (2 arms), sponsored by waleed elkhayat. Primary endpoint: Preterm birth before 37 weeks gestation. Started Jun 2010; status: recruiting.
02
Drugs
sildenafil
03
Conditions
Preterm labor (PTL)preterm birth
Beyond the preview
Go deeper on ACTRN12610001017011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001017011.